Understanding What Nsaids are not metabolized by CYP2C9: A Guide to Alternative Pathways
•
5 min read
An estimated 15% of clinically used drugs are metabolized by the polymorphic CYP2C9 enzyme, highlighting why understanding **what NSAIDs are not metabolized by CYP2C9** is critical for safe and effective pain management. Variations in this enzyme can significantly impact how individuals process certain nonsteroidal anti-inflammatory drugs, increasing the risk of adverse effects.
